SERPINE1 and cardiovascular disorder: Plasma plasminogen activator inhibitor-1 is the main inhibitor of the fibrinolytic system, and it is good evidence that higher plasma PAI-1 level may lead to the development of thromboembolytic complications [21] and cardiovascular disease [18, 22].